Americas Maria Gabriela Pittis, Head of SAM (South Cone, Andean Region, Mexico & Central America and Caribbean) at Takeda, outlines the company’s significant presence in the cluster, its double digit growth and plans to launch 14 new products there by 2025, most importantly its European Medicines Agency-approved dengue vaccine. She also…
Americas In 2019 the pharma industry financed some 700 clinical studies in Latin America with investments of more than USD one billion and according to FIFARMA, the leading association of innovators in the region, LatAm currently supports about 10 percent of the world’s clinical research. Local industry leaders discuss the advantages…
LatAm A breakdown of the investments made by the pharmaceutical industry in clinical studies across the Latin American region. According to the US National Library of Medicine’s ClinicalTrials.gov, USD 1.1 billion were invested in 2019 with Mexico, Brazil and Argentina at the head of the LatAm countries where these investments were…
LatAm As selected by the Generics & Biosimilars Initiative (GABI), these are the top ten pharma companies ranked by turnover in Argentina, Brazil, Chile, Colombia, and Mexico for 2021. As the chart shows, the Argentinian and Brazilian Top Tens are dominated by domestic companies, while multinationals hold sway in Colombia and…
LatAm Argentina Below we highlight recent news in the Latin America region, focusing on Argentina, Colombia and Chile. Top stories cover the fight against COVID-19, economic uncertainty in the Mercosur region, and Latin American involvement in disease research. Argentina to receive 45,000 virus detection tests as part of a bigger emergency…
Chile Against a backdrop of protests against Chile’s market-dominant socio-economic model, President Sebastián Piñera has announced a wave of reforms to address inequalities and improve treatment within the country’s healthcare system. However, there are no guarantees that these motions will pass in their entirety, or that they will quell public dissatisfaction…
Pharma Legal Handbook The low-down on the situation regarding patents and trademarks in Chile pharma. Prepared in association with Carey, a leading global law firm, this is an extract from The Pharma Legal Handbook: Chile, available to purchase here for GBP 99. 1. What are the basic requirements to obtain patent and…
Pharma Click here to read more articles and interviews from Peru, and to download the latest free pharma report on the country.
Roche Chile How would you assess Roche’s performance in Chile since its establishment and how has your portfolio developed in the Chilean market? Next year marks Roche’s 40th anniversary in Chile, which makes this affiliate younger than most of the other Latin American ones. This is mainly because from the beginning the…
Merck Chile What have been Merck’s major milestones and achievements for its pharmaceutical division since you took the reins? I have been managing the Pharma division of Merck since 2006 and the biggest milestone since then has definitely been the acquisition of Serono. In Chile Serono was previously represented by a local…
Genzyme Chile Genzyme was first established in Chile in 2004 but only opened its sales office in 2008, what was the rationale for the opening of the office at this time considering that you had been present in neighbouring countries 10 years before? The Chilean market is a very difficult one. We…
Pfizer Chile Last year Pfizer consolidated its position as the world´s largest global pharmaceutical company by acquiring Wyeth, of which you were previously the General Manager here in Chile. Given your privileged position as head of the combined company, how would you evaluate the integration of the two companies in Chile, and…
See our Cookie Privacy Policy Here